Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2021.577788
Abstract: Objectives To report clinical outcome, development of humoral and T-cell mediated immunity in convalescent COVID-19 people with multiple sclerosis (pwMS) treated with ofatumumab in the ALITHIOS study from a single center. Methods Testing for SARS-Cov2… read more here.
Keywords: covid people; immunity; convalescent covid; treated ofatumumab ... See more keywords